Literature DB >> 18533122

The utility of maternal depression screening in the third trimester.

J Jo Kim1, Trent E J Gordon, Laura M La Porte, Marci Adams, Jessica M Kuendig, Richard K Silver.   

Abstract

OBJECTIVE: The purpose of this study was to estimate the prevalence of maternal depressive risk in patients during the third trimester and to determine whether unique at-risk women are identified when the data are compared with postpartum screening. STUDY
DESIGN: As part of a comprehensive program for universal perinatal depression screening and behavioral health referral of at-risk women, patients completed the Edinburgh Postnatal Depression Scale both during pregnancy (24-28 weeks of gestation) and again at 6 weeks after delivery. Based on Edinburgh Postnatal Depression Scale scores of > or =12, the prevalence of antepartum depressive risk and the rates of concordant/discordant risk status with the corresponding postpartum results were calculated. Discordant-risk cases were further analyzed to determine whether obstetric, psychosocial, or demographic variables were associated with changing risk status over time.
RESULTS: We screened 1584 women in the third trimester and again after delivery: 7.7% and 6.8% of the women scored in the at-risk range in the antepartum and postpartum time frames, respectively; 88.9% of patients had the same risk status, and 11.1% were discordant before and after delivery. Statistically significant associations were found between premature birth, newborn infant admission to the intensive care nursery, and acquisition of postpartum depressive risk.
CONCLUSION: Screening for depression in the third trimester resulted in a comparable prevalence rate of depressive risk identification when compared with the postpartum time frame. Unique women were identified before and after delivery who may have been missed if screening had not been performed twice.

Entities:  

Mesh:

Year:  2008        PMID: 18533122     DOI: 10.1016/j.ajog.2008.04.018

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  7 in total

1.  Poor prepregnancy and antepartum mental health predicts postpartum mental health problems among US women: a nationally representative population-based study.

Authors:  Whitney P Witt; Lauren E Wisk; Erika R Cheng; John M Hampton; Paul D Creswell; Erika W Hagen; Hilary A Spear; Torsheika Maddox; Thomas Deleire
Journal:  Womens Health Issues       Date:  2011-02-24

2.  A model for maternal depression.

Authors:  Cynthia D Connelly; Mary J Baker-Ericzen; Andrea L Hazen; John Landsverk; Sarah McCue Horwitz
Journal:  J Womens Health (Larchmt)       Date:  2010-09       Impact factor: 2.681

3.  Antenatal depressive symptoms associated with specific life events and sources of social support among Italian women.

Authors:  Francesca Agostini; Erica Neri; Paola Salvatori; Sara Dellabartola; Laura Bozicevic; Fiorella Monti
Journal:  Matern Child Health J       Date:  2015-05

4.  Scaling Up Patient-Centered Psychological Treatments for Perinatal Depression in the Wake of a Global Pandemic.

Authors:  Daisy R Singla; Samantha Meltzer-Brody; Katarina Savel; Richard K Silver
Journal:  Front Psychiatry       Date:  2022-02-07       Impact factor: 4.157

5.  The utility of screening for perinatal depression in the second trimester among Chinese: a three-wave prospective longitudinal study.

Authors:  Ying Lau; Daniel Fu Keung Wong; Kin Sin Chan
Journal:  Arch Womens Ment Health       Date:  2010-04       Impact factor: 3.633

6.  Detection of antenatal depression in rural HIV-affected populations with short and ultrashort versions of the Edinburgh Postnatal Depression Scale (EPDS).

Authors:  Tamsen J Rochat; Mark Tomlinson; Marie-Louise Newell; Alan Stein
Journal:  Arch Womens Ment Health       Date:  2013-04-25       Impact factor: 3.633

7.  Economic and Health Predictors of National Postpartum Depression Prevalence: A Systematic Review, Meta-analysis, and Meta-Regression of 291 Studies from 56 Countries.

Authors:  Jennifer Hahn-Holbrook; Taylor Cornwell-Hinrichs; Itzel Anaya
Journal:  Front Psychiatry       Date:  2018-02-01       Impact factor: 4.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.